1. Home
  2. IQV vs DHI Comparison

IQV vs DHI Comparison

Compare IQV & DHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

N/A

Current Price

$262.33

Market Cap

35.1B

Sector

Health Care

ML Signal

N/A

Logo D.R. Horton Inc.

DHI

D.R. Horton Inc.

N/A

Current Price

$145.60

Market Cap

41.7B

ML Signal

N/A

Company Overview

Basic Information
Metric
IQV
DHI
Founded
1982
1978
Country
United States
United States
Employees
93000
14341
Industry
Biotechnology: Commercial Physical & Biological Resarch
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
35.1B
41.7B
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
IQV
DHI
Price
$262.33
$145.60
Analyst Decision
Strong Buy
Hold
Analyst Count
16
14
Target Price
$227.13
$166.08
AVG Volume (30 Days)
1.2M
1.8M
Earning Date
05-05-2026
04-21-2026
Dividend Yield
N/A
1.19%
EPS Growth
4.67
N/A
EPS
1.61
7.45
Revenue
$9,739,000,000.00
$34,250,400,000.00
Revenue This Year
$6.77
$0.05
Revenue Next Year
$5.89
$5.85
P/E Ratio
$162.43
$20.03
Revenue Growth
41.60
N/A
52 Week Low
$154.50
$131.75
52 Week High
$262.51
$183.62

Technical Indicators

Market Signals
Indicator
IQV
DHI
Relative Strength Index (RSI) 73.47 45.52
Support Level $159.91 $138.27
Resistance Level N/A $153.01
Average True Range (ATR) 7.47 3.60
MACD 0.69 0.02
Stochastic Oscillator 92.06 3.98

Price Performance

Historical Comparison
IQV
DHI

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

About DHI D.R. Horton Inc.

D.R. Horton is the largest homebuilder in the United States with operations in 126 markets across 36 states. D.R. Horton mainly builds single-family homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. The firm has majority ownership of Forestar Group, a publicly traded residential lot development company. D.R. Horton's headquarters are in Arlington, Texas.

Share on Social Networks: